Its intriguing. A doubling of staff at the Irish plant indicates to me that AbbVie thinks Humira sales will um double, rather than halve, as a result of competition against biosimilars. If The Big Fella's words that we are AbbVie's "preferred partner for differentiated devices etc" are true then there has to be some kind of link between this investment and our relationship with AbbVie. Who knows, maybe AbbVie will license out the Lisa and build it themselves at the plant.
Whether this is a positive or negative for us, one would think this Irish investment was on AbbVie's radar when they handed over $5 million to us in January....
UNS Price at posting:
46.0¢ Sentiment: Buy Disclosure: Held